{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:35:59Z","timestamp":1791513359041,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05234-4","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T10:26:25Z","timestamp":1754043985000},"page":"16229-16260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Resveratrol's Multifaceted Potential in Alzheimer\u2019s Disease: Insights from Preclinical and Clinical Evidence"],"prefix":"10.1007","volume":"62","author":[{"given":"Shivani","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur S.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"5234_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04285-3","author":"A Ortega","year":"2024","unstructured":"Ortega A, Chernicki B, Ou G, Parmar MS (2024) From lab bench to hope: emerging gene therapies in clinical trials for Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04285-3","journal-title":"Mol Neurobiol"},{"key":"5234_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","volume":"44","author":"L Zhao","year":"2016","unstructured":"Zhao L, Gottesdiener AJ, Parmar M, Li M, Kaminsky SM, Chiuchiolo MJ, Sondhi D, Sullivan PM et al (2016) Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models. Neurobiol Aging 44:159\u2013172. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.04.020","journal-title":"Neurobiol Aging"},{"key":"5234_CR3","doi-asserted-by":"publisher","first-page":"123001","DOI":"10.1016\/j.lfs.2024.123001","volume":"355","author":"J Tran","year":"2024","unstructured":"Tran J, Parekh S, Rockcole J, Wilson D, Parmar MS (2024) Repurposing antidiabetic drugs for Alzheimer\u2019s disease: a review of preclinical and clinical evidence and overcoming challenges. Life Sci 355:123001. https:\/\/doi.org\/10.1016\/j.lfs.2024.123001","journal-title":"Life Sci"},{"issue":"3","key":"5234_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, Hendrix S, Selkoe D et al (2023) Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis 10(3):362\u2013377. https:\/\/doi.org\/10.14283\/jpad.2023.30","journal-title":"J Prev Alzheimers Dis"},{"key":"5234_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainres.2014.05.028","volume":"1573","author":"KM Rose","year":"2014","unstructured":"Rose KM, Parmar MS, Cavanaugh JE (2014) Dietary supplementation with resveratrol protects against striatal dopaminergic deficits produced by in utero LPS exposure. Brain Res 1573:37\u201343","journal-title":"Brain Res"},{"key":"5234_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jnutbio.2017.10.015","volume":"54","author":"EN Allen","year":"2018","unstructured":"Allen EN, Potdar S, Tapias V, Parmar M, Mizuno CS, Rimando A, Cavanaugh JE (2018) Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1\/2 dependent-mechanism. J Nutr Biochem 54:77\u201386","journal-title":"J Nutr Biochem"},{"issue":"2","key":"5234_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00204-017-2073-z","volume":"92","author":"S Potdar","year":"2018","unstructured":"Potdar S, Parmar MS, Ray SD, Cavanaugh JE (2018) Protective effects of the resveratrol analog piceid in dopaminergic SH-SY5Y cells. Arch Toxicol 92(2):669\u2013677. https:\/\/doi.org\/10.1007\/s00204-017-2073-z","journal-title":"Arch Toxicol"},{"issue":"1","key":"5234_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"C Moussa","year":"2017","unstructured":"Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS (2017) Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J Neuroinflammation 14(1):1. https:\/\/doi.org\/10.1186\/s12974-016-0779-0","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5234_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-024-00792-1","volume":"21","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A, Abutalebian F (2024) Unraveling the therapeutic efficacy of resveratrol in Alzheimer\u2019s disease: an umbrella review of systematic evidence. Nutr Metab (Lond) 21(1):15. https:\/\/doi.org\/10.1186\/s12986-024-00792-1","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"5234_CR10","first-page":"395","volume":"49","author":"M Sharma","year":"2005","unstructured":"Sharma M, Briyal S, Gupta YK (2005) Effect of alpha lipoic acid, melatonin and trans resveratrol on intracerebroventricular streptozotocin induced spatial memory deficit in rats. Indian J Physiol Pharmacol 49(4):395\u2013402","journal-title":"Indian J Physiol Pharmacol"},{"issue":"13","key":"5234_CR11","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","volume":"26","author":"D Kim","year":"2007","unstructured":"Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis. EMBO J 26(13):3169\u20133179. https:\/\/doi.org\/10.1038\/sj.emboj.7601758","journal-title":"EMBO J"},{"issue":"2","key":"5234_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","volume":"54","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease. Neurochem Int 54(2):111\u2013118. https:\/\/doi.org\/10.1016\/j.neuint.2008.10.008","journal-title":"Neurochem Int"},{"issue":"12","key":"5234_CR13","doi-asserted-by":"publisher","first-page":"e29102","DOI":"10.1371\/journal.pone.0029102","volume":"6","author":"TC Huang","year":"2011","unstructured":"Huang TC, Lu KT, Wo YYP, Wu YJ, Yang YL (2011) Resveratrol protects rats from A\u03b2-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS ONE 6(12):e29102. https:\/\/doi.org\/10.1371\/journal.pone.0029102","journal-title":"PLoS ONE"},{"issue":"5","key":"5234_CR14","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s11357-012-9489-4","volume":"35","author":"D Porquet","year":"2013","unstructured":"Porquet D, Casades\u00fas G, Bayod S, Vicente A, Canudas AM, Vilaplana J, Pelegr\u00ed C, Sanfeliu C et al (2013) Dietary resveratrol prevents Alzheimer\u2019s markers and increases life span in SAMP8. Age (Dordr) 35(5):1851\u20131865. https:\/\/doi.org\/10.1007\/s11357-012-9489-4","journal-title":"Age (Dordr)"},{"issue":"4","key":"5234_CR15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3233\/jad-140444","volume":"42","author":"D Porquet","year":"2014","unstructured":"Porquet D, Gri\u00f1\u00e1n-Ferr\u00e9 C, Ferrer I, Camins A, Sanfeliu C, Del Valle J, Pall\u00e0s M (2014) Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer\u2019s disease. J Alzheimers Dis 42(4):1209\u20131220. https:\/\/doi.org\/10.3233\/jad-140444","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5234_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3233\/jad-131031","volume":"40","author":"NO Solberg","year":"2014","unstructured":"Solberg NO, Chamberlin R, Vigil JR, Deck LM, Heidrich JE, Brown DC, Brady CI, Vander Jagt TA et al (2014) Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-\u03baB concomitantly lower Alzheimer\u2019s disease plaque formation and microglial activation in A\u03b2PP\/PS-1 transgenic mouse brain. J Alzheimers Dis 40(1):191\u2013212. https:\/\/doi.org\/10.3233\/jad-131031","journal-title":"J Alzheimers Dis"},{"key":"5234_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-3-319-08927-0_12","volume":"822","author":"NS El-Sayed","year":"2015","unstructured":"El-Sayed NS, Bayan Y (2015) Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease. Adv Exp Med Biol 822:107\u2013118. https:\/\/doi.org\/10.1007\/978-3-319-08927-0_12","journal-title":"Adv Exp Med Biol"},{"key":"5234_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.neuroscience.2015.10.006","volume":"310","author":"HF Zhao","year":"2015","unstructured":"Zhao HF, Li N, Wang Q, Cheng XJ, Li XM, Liu TT (2015) Resveratrol decreases the insoluble A\u03b21-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 310:641\u2013649. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.10.006","journal-title":"Neuroscience"},{"key":"5234_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnmol.2016.00028","volume":"9","author":"C Karthick","year":"2016","unstructured":"Karthick C, Periyasamy S, Jayachandran KS, Anusuyadevi M (2016) Intrahippocampal administration of ibotenic acid induced cholinergic dysfunction via NR2A\/NR2B expression: implications of resveratrol against Alzheimer disease pathophysiology. Front Mol Neurosci 9:28. https:\/\/doi.org\/10.3389\/fnmol.2016.00028","journal-title":"Front Mol Neurosci"},{"key":"5234_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2119\/molmed.2016.00124","volume":"22","author":"LM Santos","year":"2016","unstructured":"Santos LM, Rodrigues D, Alemi M, Silva SC, Ribeiro CA, Cardoso I (2016) Resveratrol administration increases transthyretin protein levels ameliorating AD features- importance of transthyretin tetrameric stability. Mol Med 22:597\u2013607. https:\/\/doi.org\/10.2119\/molmed.2016.00124","journal-title":"Mol Med"},{"issue":"14","key":"5234_CR21","doi-asserted-by":"publisher","first-page":"17380","DOI":"10.18632\/oncotarget.8041","volume":"7","author":"G Wang","year":"2016","unstructured":"Wang G, Chen L, Pan X, Chen J, Wang L, Wang W, Cheng R, Wu F et al (2016) The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling. Oncotarget 7(14):17380\u201317392. https:\/\/doi.org\/10.18632\/oncotarget.8041","journal-title":"Oncotarget"},{"issue":"8","key":"5234_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2174\/1567205014666170207093455","volume":"14","author":"J Cheng","year":"2017","unstructured":"Cheng J, Rui Y, Qin L, Xu J, Han S, Yuan L, Yin X, Wan Z (2017) Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice. Curr Alzheimer Res 14(8):820\u2013833. https:\/\/doi.org\/10.2174\/1567205014666170207093455","journal-title":"Curr Alzheimer Res"},{"key":"5234_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbr.2017.10.032","volume":"339","author":"X Wang","year":"2018","unstructured":"Wang X, Ma S, Yang B, Huang T, Meng N, Xu L, Xing Q, Zhang Y et al (2018) Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer\u2019s disease. Behav Brain Res 339:297\u2013304. https:\/\/doi.org\/10.1016\/j.bbr.2017.10.032","journal-title":"Behav Brain Res"},{"issue":"10","key":"5234_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/jcm7100329","volume":"7","author":"YT Lin","year":"2018","unstructured":"Lin YT, Wu YC, Sun GC, Ho CY, Wong TY, Lin CH, Chen HH, Yeh TC et al (2018) Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer\u2019s disease. J Clin Med 7(10):329. https:\/\/doi.org\/10.3390\/jcm7100329","journal-title":"J Clin Med"},{"issue":"5","key":"5234_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s13346-018-0540-6","volume":"8","author":"A Rajput","year":"2018","unstructured":"Rajput A, Bariya A, Allam A, Othman S, Butani SB (2018) In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization. Drug Deliv Transl Res 8(5):1460\u20131470. https:\/\/doi.org\/10.1007\/s13346-018-0540-6","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"5234_CR26","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-018-1157-y","volume":"56","author":"R Corpas","year":"2019","unstructured":"Corpas R, Gri\u00f1\u00e1n-Ferr\u00e9 C, Rodr\u00edguez-Farr\u00e9 E, Pall\u00e0s M, Sanfeliu C (2019) Resveratrol induces Brain resilience against Alzheimer neurodegeneration through proteostasis enhancement. Mol Neurobiol 56(2):1502\u20131516. https:\/\/doi.org\/10.1007\/s12035-018-1157-y","journal-title":"Mol Neurobiol"},{"issue":"10","key":"5234_CR27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/1061186x.2019.1608553","volume":"27","author":"HF Salem","year":"2019","unstructured":"Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM (2019) Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles: in vivo evaluation and bioaccumulation investigation using computed tomography and histopathological examination. J Drug Target 27(10):1127\u20131134. https:\/\/doi.org\/10.1080\/1061186x.2019.1608553","journal-title":"J Drug Target"},{"key":"5234_CR28","doi-asserted-by":"publisher","first-page":"8983752","DOI":"10.1155\/2019\/8983752","volume":"2019","author":"D Kong","year":"2019","unstructured":"Kong D, Yan Y, He XY, Yang H, Liang B, Wang J, He Y, Ding Y et al (2019) Effects of resveratrol on the mechanisms of antioxidants and estrogen in Alzheimer\u2019s disease. Biomed Res Int 2019:8983752. https:\/\/doi.org\/10.1155\/2019\/8983752","journal-title":"Biomed Res Int"},{"key":"5234_CR29","doi-asserted-by":"publisher","first-page":"9454913","DOI":"10.1155\/2019\/9454913","volume":"2019","author":"L Lin","year":"2019","unstructured":"Lin L, Liu G, Yang L (2019) Crocin improves cognitive behavior in rats with Alzheimer\u2019s disease by regulating endoplasmic reticulum stress and apoptosis. BioMed Res Int 2019:9454913. https:\/\/doi.org\/10.1155\/2019\/9454913","journal-title":"BioMed Res Int"},{"issue":"8","key":"5234_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1567205016666190801153751","volume":"16","author":"XY Sun","year":"2019","unstructured":"Sun XY, Dong QX, Zhu J, Sun X, Zhang LF, Qiu M, Yu XL, Liu RT (2019) Resveratrol rescues tau-induced cognitive deficits and neuropathology in a mouse model of tauopathy. Curr Alzheimer Res 16(8):710\u2013722. https:\/\/doi.org\/10.2174\/1567205016666190801153751","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"5234_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11011-018-0348-6","volume":"34","author":"Y Qi","year":"2019","unstructured":"Qi Y, Shang L, Liao Z, Su H, Jing H, Wu B, Bi K, Jia Y (2019) Intracerebroventricular injection of resveratrol ameliorated A\u03b2-induced learning and cognitive decline in mice. Metab Brain Dis 34(1):257\u2013266. https:\/\/doi.org\/10.1007\/s11011-018-0348-6","journal-title":"Metab Brain Dis"},{"issue":"1","key":"5234_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","volume":"27","author":"Y Han","year":"2020","unstructured":"Han Y, Chu X, Cui L, Fu S, Gao C, Li Y, Sun B (2020) Neuronal mitochondria-targeted therapy for Alzheimer\u2019s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Drug Deliv 27(1):502\u2013518. https:\/\/doi.org\/10.1080\/10717544.2020.1745328","journal-title":"Drug Deliv"},{"key":"5234_CR33","doi-asserted-by":"publisher","first-page":"112983","DOI":"10.1016\/j.jep.2020.112983","volume":"260","author":"S Liu","year":"2020","unstructured":"Liu S, Li Y, Yi F, Liu Q, Chen N, He X, He C, Xiao P (2020) Resveratrol oligomers from Paeonia suffruticosa protect mice against cognitive dysfunction by regulating cholinergic, antioxidant and anti-inflammatory pathways. J Ethnopharmacol 260:112983. https:\/\/doi.org\/10.1016\/j.jep.2020.112983","journal-title":"J Ethnopharmacol"},{"key":"5234_CR34","doi-asserted-by":"publisher","first-page":"119844","DOI":"10.1016\/j.biomaterials.2020.119844","volume":"238","author":"P Yang","year":"2020","unstructured":"Yang P, Sheng D, Guo Q, Wang P, Xu S, Qian K, Li Y, Cheng Y et al (2020) Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer\u2019s disease. Biomaterials 238:119844. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119844","journal-title":"Biomaterials"},{"issue":"2","key":"5234_CR35","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.18632\/aging.102713","volume":"12","author":"K Cao","year":"2020","unstructured":"Cao K, Dong YT, Xiang J, Xu Y, Li Y, Song H, Yu WF, Qi XL et al (2020) The neuroprotective effects of SIRT1 in mice carrying the APP\/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670\/671 may involve elevated levels of \u03b17 nicotinic acetylcholine receptors. Aging (Albany NY) 12(2):1792\u20131807. https:\/\/doi.org\/10.18632\/aging.102713","journal-title":"Aging (Albany NY)"},{"key":"5234_CR36","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fnins.2019.01400","volume":"13","author":"X Ma","year":"2019","unstructured":"Ma X, Sun Z, Han X, Li S, Jiang X, Chen S, Zhang J, Lu H (2019) Neuroprotective effect of resveratrol via activation of Sirt1 signaling in a rat model of combined diabetes and Alzheimer\u2019s disease. Front Neurosci 13:1400. https:\/\/doi.org\/10.3389\/fnins.2019.01400","journal-title":"Front Neurosci"},{"key":"5234_CR37","doi-asserted-by":"publisher","first-page":"108569","DOI":"10.1016\/j.jnutbio.2020.108569","volume":"89","author":"S Sarroca","year":"2021","unstructured":"Sarroca S, Gatius A, Rodr\u00edguez-Farr\u00e9 E, Vilchez D, Pall\u00e0s M, Gri\u00f1\u00e1n-Ferr\u00e9 C, Sanfeliu C, Corpas R (2021) Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer\u2019s disease via modulation of proteolytic mechanisms. J Nutr Biochem 89:108569. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108569","journal-title":"J Nutr Biochem"},{"issue":"19","key":"5234_CR38","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.3390\/ijms21197337","volume":"21","author":"TL Broderick","year":"2020","unstructured":"Broderick TL, Rasool S, Li R, Zhang Y, Anderson M, Al-Nakkash L, Plochocki JH et al (2020) Neuroprotective effects of chronic resveratrol treatment and exercise training in the 3xTg-AD mouse model of Alzheimer\u2019s disease. Int J Mol Sci 21(19):7337. https:\/\/doi.org\/10.3390\/ijms21197337","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5234_CR39","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/pharmaceutics13101635","volume":"13","author":"H Abbas","year":"2021","unstructured":"Abbas H, Gad HA, Khattab MA, Mansour M (2021) The tragedy of Alzheimer\u2019s disease: towards better management via resveratrol-loaded oral bilosomes. Pharmaceutics 13(10):1635. https:\/\/doi.org\/10.3390\/pharmaceutics13101635","journal-title":"Pharmaceutics"},{"issue":"7","key":"5234_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13205-021-02879-5","volume":"11","author":"YL Rao","year":"2021","unstructured":"Rao YL, Ganaraja B, Marathe A, Manjrekar PA, Joy T, Ullal S, Pai MM, Murlimanju BV (2021) Comparison of malondialdehyde levels and superoxide dismutase activity in resveratrol and resveratrol\/donepezil combination treatment groups in Alzheimer\u2019s disease induced rat model. 3 Biotech 11(7):329. https:\/\/doi.org\/10.1007\/s13205-021-02879-5","journal-title":"3 Biotech"},{"issue":"39","key":"5234_CR41","doi-asserted-by":"publisher","first-page":"46406","DOI":"10.1021\/acsami.1c14818","volume":"13","author":"C Li","year":"2021","unstructured":"Li C, Wang N, Zheng G, Yang L (2021) Oral administration of resveratrol-selenium-peptide nanocomposites alleviates Alzheimer\u2019s disease-like pathogenesis by inhibiting A\u03b2 aggregation and regulating gut microbiota. ACS Appl Mater Interfaces 13(39):46406\u201346420. https:\/\/doi.org\/10.1021\/acsami.1c14818","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"5234_CR42","doi-asserted-by":"publisher","first-page":"e10459","DOI":"10.1002\/btm2.10459","volume":"8","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhao Y, Guo K, Tian H, Wang C, Wang R, Chen Y, Chen X et al (2023) Macromolecular nanoparticles to attenuate both reactive oxygen species and inflammatory damage for treating Alzheimer\u2019s disease. Bioeng Transl Med 8(3):e10459. https:\/\/doi.org\/10.1002\/btm2.10459","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"5234_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/jad-215370","volume":"86","author":"JL Dennison","year":"2022","unstructured":"Dennison JL, Volmar CH, Modarresi F, Ke D, Wang J, Gravel E, Hammond-Vignini S, Li Z et al (2022) JOTROL, a novel formulation of resveratrol, shows beneficial effects in the 3xTg-AD mouse model. J Alzheimers Dis 86(1):173\u2013190. https:\/\/doi.org\/10.3233\/jad-215370","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"5234_CR44","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1007\/s12011-021-03073-7","volume":"200","author":"OAR Abozaid","year":"2022","unstructured":"Abozaid OAR, Sallam MW, El-Sonbaty S, Aziza S, Emad B, Ahmed ESA (2022) Resveratrol-selenium nanoparticles alleviate neuroinflammation and neurotoxicity in a rat model of Alzheimer\u2019s disease by regulating Sirt1\/miRNA-134\/GSK3\u03b2 expression. Biol Trace Elem Res 200(12):5104\u20135114. https:\/\/doi.org\/10.1007\/s12011-021-03073-7","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"5234_CR45","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s11064-022-03622-z","volume":"47","author":"D Ibi","year":"2022","unstructured":"Ibi D, Kondo S, Ohmi A, Kojima Y, Nakasai G, Takaba R, Hiramatsu M (2022) Preventive effect of betaine against cognitive impairments in amyloid \u03b2 peptide-injected mice through sirtuin1 in hippocampus. Neurochem Res 47(8):2333\u20132344. https:\/\/doi.org\/10.1007\/s11064-022-03622-z","journal-title":"Neurochem Res"},{"issue":"14","key":"5234_CR46","doi-asserted-by":"publisher","first-page":"7580","DOI":"10.3390\/ijms23147580","volume":"23","author":"A S\u00e1nchez-Melgar","year":"2022","unstructured":"S\u00e1nchez-Melgar A, Izquierdo-Ram\u00edrez PJ, Gri\u00f1\u00e1n-Ferr\u00e9 C, Pall\u00e0s M, Mart\u00edn M, Albasanz JL (2022) Neuroprotective effects of resveratrol by modifying cholesterol metabolism and A\u03b2 processing in SAMP8 mice. Int J Mol Sci 23(14):7580. https:\/\/doi.org\/10.3390\/ijms23147580","journal-title":"Int J Mol Sci"},{"key":"5234_CR47","doi-asserted-by":"publisher","first-page":"877098","DOI":"10.3389\/fphar.2022.877098","volume":"13","author":"L Zhu","year":"2022","unstructured":"Zhu L, Lu F, Zhang X, Liu S, Mu P (2022) SIRT1 is involved in the neuroprotection of pterostilbene against amyloid \u03b2 25\u201335-induced cognitive deficits in mice. Front Pharmacol 13:877098. https:\/\/doi.org\/10.3389\/fphar.2022.877098","journal-title":"Front Pharmacol"},{"key":"5234_CR48","doi-asserted-by":"publisher","first-page":"1115721","DOI":"10.3389\/fphar.2023.1115721","volume":"14","author":"AI Foudah","year":"2023","unstructured":"Foudah AI, Devi S, Alam A, Salkini MA, Ross SA (2023) Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer\u2019s disease in rats: mechanistic approach to prevent inflammation. Front Pharmacol 14:1115721. https:\/\/doi.org\/10.3389\/fphar.2023.1115721","journal-title":"Front Pharmacol"},{"key":"5234_CR49","doi-asserted-by":"publisher","first-page":"124316","DOI":"10.1016\/j.ijbiomac.2023.124316","volume":"239","author":"L Yang","year":"2023","unstructured":"Yang L, Wang Y, Zheng G, Li Z, Mei J (2023) Resveratrol-loaded selenium\/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer\u2019s disease. Int J Biol Macromol 239:124316. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124316","journal-title":"Int J Biol Macromol"},{"key":"5234_CR50","doi-asserted-by":"publisher","first-page":"120714","DOI":"10.1016\/j.carbpol.2023.120714","volume":"310","author":"L Yang","year":"2023","unstructured":"Yang L, Wang Y, Li Z, Wu X, Mei J, Zheng G (2023) Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease. Carbohydr Polym 310:120714. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120714","journal-title":"Carbohydr Polym"},{"issue":"9","key":"5234_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/03639045.2023.2252062","volume":"49","author":"MH Chen","year":"2023","unstructured":"Chen MH, Liu XZ, Qu XW, Guo RB, Zhang L, Kong L, Yu Y, Liu Y et al (2023) ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer\u2019s disease in APP\/PS-1 mice. Drug Dev Ind Pharm 49(9):559\u2013571. https:\/\/doi.org\/10.1080\/03639045.2023.2252062","journal-title":"Drug Dev Ind Pharm"},{"key":"5234_CR52","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.nano.2023.102689","volume":"51","author":"B Fonseca-Santos","year":"2023","unstructured":"Fonseca-Santos B, Cazarin CA, da Silva PB, Dos Santos KP, da Rocha MCO, B\u00e1o SN, De-Souza MM, Chorilli M (2023) Intranasal in situ gelling liquid crystal for delivery of resveratrol ameliorates memory and neuroinflammation in Alzheimer\u2019s disease. Nanomedicine 51:102689. https:\/\/doi.org\/10.1016\/j.nano.2023.102689","journal-title":"Nanomedicine"},{"issue":"9","key":"5234_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13205-023-03743-4","volume":"13","author":"YL Rao","year":"2023","unstructured":"Rao YL, Ganaraja B, Suresh PK, Joy T, Ullal SD, Manjrekar PA, Murlimanju BV, Sharma BG (2023) Effect of resveratrol and combination of resveratrol and donepezil on the expression of microglial cells and astrocytes in. 3 Biotech 13(9):319. https:\/\/doi.org\/10.1007\/s13205-023-03743-4","journal-title":"3 Biotech"},{"issue":"8","key":"5234_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s13205-024-04034-2","volume":"14","author":"YL Rao","year":"2024","unstructured":"Rao YL, Ganaraja B, Suresh PK, Joy T, Ullal SD, Manjrekar PA, Murlimanju BV, Sharma BG et al (2024) Outcome of resveratrol and resveratrol with donepezil combination on the \u03b2-amyloid plaques and neurofibrillary tangles in Alzheimer\u2019s disease. 3 Biotech 14(8):190. https:\/\/doi.org\/10.1007\/s13205-024-04034-2","journal-title":"3 Biotech"},{"key":"5234_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17373","author":"G Tao","year":"2024","unstructured":"Tao G, Wang X, Wang J, Ye Y, Zhang M, Lang Y, Ding S (2024) Dihydro-resveratrol ameliorates NLRP3 inflammasome-mediated neuroinflammation via Bnip3-dependent mitophagy in Alzheimer\u2019s disease. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.17373","journal-title":"Br J Pharmacol"},{"issue":"23","key":"5234_CR56","doi-asserted-by":"publisher","first-page":"12777","DOI":"10.3390\/ijms252312777","volume":"25","author":"M Lazarova","year":"2024","unstructured":"Lazarova M, Stefanova M, Tsvetanova E, Georgieva A, Tasheva K, Radeva L, Yoncheva K (2024) Resveratrol-loaded pluronic micelles ameliorate scopolamine-induced cognitive dysfunction targeting acetylcholinesterase activity and programmed cell death. Int J Mol Sci 25(23):12777. https:\/\/doi.org\/10.3390\/ijms252312777","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5234_CR57","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s10787-024-01476-1","volume":"32","author":"Z Wang","year":"2024","unstructured":"Wang Z, Gao C, Zhang L, Sui R (2024) Novel combination of olesoxime\/resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid \u03b2-induced Alzheimer\u2019s disease: investigation on in vitro and in vivo model. Inflammopharmacology 32(4):2613\u20132628. https:\/\/doi.org\/10.1007\/s10787-024-01476-1","journal-title":"Inflammopharmacology"},{"issue":"5","key":"5234_CR58","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/1028415x.2023.2208908","volume":"27","author":"A Bhounsule","year":"2024","unstructured":"Bhounsule A, Bhatt LK (2024) Protective effect of resveratrol and tannic acid combination on aluminium chloride induced neurotoxicity in rats. Nutr Neurosci 27(5):438\u2013450. https:\/\/doi.org\/10.1080\/1028415x.2023.2208908","journal-title":"Nutr Neurosci"},{"key":"5234_CR59","doi-asserted-by":"publisher","first-page":"7877265","DOI":"10.1155\/2024\/7877265","volume":"2024","author":"MA Khishvand","year":"2024","unstructured":"Khishvand MA, Yeganeh EM, Zarei M, Soleimani M, Mohammadi M, Mahjub R (2024) Development, statistical optimization, and characterization of resveratrol-containing solid lipid nanoparticles (SLNs) and determination of the efficacy in reducing neurodegenerative symptoms related to Alzheimer\u2019s disease: in vitro and in vivo study. Biomed Res Int 2024:7877265. https:\/\/doi.org\/10.1155\/2024\/7877265","journal-title":"Biomed Res Int"},{"key":"5234_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8395","author":"JJ Heo","year":"2024","unstructured":"Heo JJ, Han YE, Kim MS, Cheong E, Choi CW, Oh SJ (2024) Suffruticosol B from Paeonia lactiflora ameliorates Alzheimer\u2019s disease pathology by inhibiting MAO-B activity. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.8395","journal-title":"Phytother Res"},{"issue":"16","key":"5234_CR61","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms23168972","volume":"23","author":"E Sun","year":"2022","unstructured":"Sun E, Motolani A, Campos L, Lu T (2022) The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci 23(16):8972. https:\/\/doi.org\/10.3390\/ijms23168972","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5234_CR62","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07594.x","volume":"120","author":"H Capiralla","year":"2012","unstructured":"Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P, Marambaud P (2012) Resveratrol mitigates lipopolysaccharide- and A\u03b2-mediated microglial inflammation by inhibiting the TLR4\/NF-\u03baB\/STAT signaling cascade. J Neurochem 120(3):461\u2013472. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07594.x","journal-title":"J Neurochem"},{"key":"5234_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.biomaterials.2018.12.027","volume":"197","author":"J Sun","year":"2019","unstructured":"Sun J, Wei C, Liu Y, Xie W, Xu M, Zhou H, Liu J (2019) Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer\u2019s disease. Biomaterials 197:417\u2013431. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.12.027","journal-title":"Biomaterials"},{"issue":"16","key":"5234_CR64","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/wnl.0000000000002035","volume":"85","author":"RS Turner","year":"2015","unstructured":"Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA et al (2015) A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85(16):1383\u20131391. https:\/\/doi.org\/10.1212\/wnl.0000000000002035","journal-title":"Neurology"},{"issue":"Pt A","key":"5234_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.exger.2016.10.004","volume":"87","author":"J Lee","year":"2017","unstructured":"Lee J, Torosyan N, Silverman DH (2017) Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: a double-blinded placebo controlled pilot study. Exp Gerontol 87(Pt A):121\u2013128. https:\/\/doi.org\/10.1016\/j.exger.2016.10.004","journal-title":"Exp Gerontol"},{"issue":"11","key":"5234_CR66","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1016\/j.clnu.2021.09.020","volume":"40","author":"I Parilli-Moser","year":"2021","unstructured":"Parilli-Moser I, Dom\u00ednguez-L\u00f3pez I, Trius-Soler M, Castellv\u00ed M, Bosch B, Castro-Barquero S, Estruch R, Hurtado-Barroso S et al (2021) Consumption of peanut products improves memory and stress response in healthy adults from the ARISTOTLE study: a 6-month randomized controlled trial. Clin Nutr 40(11):5556\u20135567. https:\/\/doi.org\/10.1016\/j.clnu.2021.09.020","journal-title":"Clin Nutr"},{"key":"5234_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fnins.2017.00105","volume":"11","author":"T K\u00f6be","year":"2017","unstructured":"K\u00f6be T, Witte AV, Schnelle A, Tesky VA, Pantel J, Schuchardt JP, Hahn A, Bohlken J et al (2017) Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment. Front Neurosci 11:105. https:\/\/doi.org\/10.3389\/fnins.2017.00105","journal-title":"Front Neurosci"},{"key":"5234_CR68","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.trci.2018.09.009","volume":"4","author":"CW Zhu","year":"2018","unstructured":"Zhu CW, Grossman H, Neugroschl J, Parker S, Burden A, Luo X, Sano M (2018) A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer\u2019s disease: a pilot study. Alzheimers Dement (N Y) 4:609\u2013616. https:\/\/doi.org\/10.1016\/j.trci.2018.09.009","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"5234_CR69","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40120-021-00271-2","volume":"10","author":"J Gu","year":"2021","unstructured":"Gu J, Li Z, Chen H, Xu X, Li Y, Gui Y (2021) Neuroprotective effect of trans-resveratrol in mild to moderate Alzheimer disease: a randomized, double-blind trial. Neurol Ther 10(2):905\u2013917. https:\/\/doi.org\/10.1007\/s40120-021-00271-2","journal-title":"Neurol Ther"},{"issue":"1","key":"5234_CR70","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/nyas.13431","volume":"1403","author":"C Sawda","year":"2017","unstructured":"Sawda C, Moussa C, Turner RS (2017) Resveratrol for Alzheimer\u2019s disease. Ann N Y Acad Sci 1403(1):142\u2013149. https:\/\/doi.org\/10.1111\/nyas.13431","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5234_CR71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/biof.1410","volume":"44","author":"P Wang","year":"2018","unstructured":"Wang P, Sang S (2018) Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors 44(1):16\u201325. https:\/\/doi.org\/10.1002\/biof.1410","journal-title":"BioFactors"},{"issue":"6","key":"5234_CR72","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/ijms20061381","volume":"20","author":"A Chimento","year":"2019","unstructured":"Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C, Pezzi V (2019) Progress to improve oral bioavailability and beneficial effects of resveratrol. Int J Mol Sci 20(6):1381. https:\/\/doi.org\/10.3390\/ijms20061381","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5234_CR73","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/ijms25020747","volume":"25","author":"K Brown","year":"2024","unstructured":"Brown K, Theofanous D, Britton RG, Aburido G, Pepper C, Sri Undru S, Howells L (2024) Resveratrol for the management of human health: how far have we come? A systematic review of resveratrol clinical trials to highlight gaps and opportunities. Int J Mol Sci 25(2):747. https:\/\/doi.org\/10.3390\/ijms25020747","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5234_CR74","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1002\/alz.14073","volume":"20","author":"V Devanarayan","year":"2024","unstructured":"Devanarayan V, Doherty T, Charil A, Sachdev P, Ye Y, Murali LK, Llano DA, Zhou J et al (2024) Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer\u2019s disease. Alzheimers Dement 20(8):5617\u20135628. https:\/\/doi.org\/10.1002\/alz.14073","journal-title":"Alzheimers Dement"},{"issue":"4","key":"5234_CR75","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jamaneurol.2024.5017","volume":"82","author":"L VandeVrede","year":"2025","unstructured":"VandeVrede L, Cho H, Sanderson-Cimino M, Wekselman F, Cobigo Y, Gorno-Tempini ML, Heuer HW, Kramer JH et al (2025) Detection of Alzheimer neuropathology in Alzheimer and non-Alzheimer clinical syndromes with blood-based biomarkers. JAMA Neurol 82(4):344\u2013354. https:\/\/doi.org\/10.1001\/jamaneurol.2024.5017","journal-title":"JAMA Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05234-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:03:45Z","timestamp":1761908625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5234"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05234-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"No consent is needed, as the study did not involve human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"No consent is needed, as this manuscript contains no personal data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}